Obstructive sleep apnea (OSA) is a complex disorder characterized by collapse of the upper
airway during sleep. Downstream effects involve the cardiovascular, pulmonary, and …

Obstructive sleep apnea (OSA) is probably the most common respiratory disorder, with
recent data from the United States and Europe suggesting that between 14% and 49% of …

Obstructive sleep apnea (OSA) is characterised by recurring episodes of upper airway
obstruction during sleep and the fundamental abnormality reflects the inability of the upper …

Background Obstructive sleep apnea (OSA) is a risk factor for several diseases and is
correlated with other non-medical consequences that increase the disease's clinical and …

Rationale: Current therapies for obstructive sleep apnea (OSA) are limited by insufficient
efficacy, compliance, or tolerability. An effective pharmacological treatment for OSA is …

BACKGROUND OSA is associated with an increased risk of cardiovascular morbidity. A
driver of this is metabolic dysfunction and in particular type 2 diabetes mellitus (T2DM). Prior …

There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

Background: Various models and questionnaires have been developed for screening
specific populations for obstructive sleep apnea (OSA) as defined by the apnea/hypopnea …

Obstructive sleep apnea is a sleep-related breathing disorder that has a major impact on
cardiovascular function. It has been associated with hypertension, coronary artery disease …

Obstructive sleep apnoea (OSA) is increasingly being recognized as an important health
issue in the last two to three decades. It is characterized by frequent episodes of upper …